The influence of endothelin-A receptor gene polymorphism on the progression of autosomal dominant polycystic kidney disease and IgA nephropathy

Folia Biologica

Volumn 53, Issue 4, 2007, Pages 134-137

  Reiterová, Jana ^a   Merta, M ^a   Stekrova J ^a   Maixnerova D ^a   Obeidova H ^a   Kebrdlova V ^a   Viklicky O ^b   Tesar V ^a  

^a CHARLES UNIVERSITY   (Czech Republic)

^b INSTITUTE FOR CLINICAL AND EXPERIMENTAL MEDICINE   (Czech Republic)

Author keywords

ADPKD; End stage renal disease; Endothelin A receptor; IgA nephropathy; Polymorphism

Indexed keywords

ANTIHYPERTENSIVE AGENT; CYTOSINE; ENDOTHELIN A RECEPTOR; IMMUNOGLOBULIN A; THYMINE;

ADULT; ARTICLE; AUTOSOMAL DOMINANT INHERITANCE; CONTROLLED STUDY; DISEASE COURSE; DNA POLYMORPHISM; EXON; FEMALE; GENE IDENTIFICATION; GENE LOCATION; GENETIC CODE; GENETIC RISK; GENOTYPE; HETEROZYGOTE; HISTOPATHOLOGY; HUMAN; HYPERTENSION; IMMUNOGLOBULIN A NEPHROPATHY; KIDNEY FAILURE; KIDNEY POLYCYSTIC DISEASE; MAJOR CLINICAL STUDY; MALE; PULSE PRESSURE; RISK ASSESSMENT; SCORING SYSTEM;

EID: 34447330120     PISSN: 00155500     EISSN: 25337602     Source Type: Journal    
DOI: None     Document Type: Article

References (26)

1. Benetos, A., Safar, M., Rudnichi, A. (1997) Pulse pressure. A predictor of long-term cardiovascular mortality in a French male population. Hypertension 30, 1410-1415.
2. Benjafield, A. V., Katyk, K., Morris, B. J. (2003) Association of EDNRA, but not WNK4 of FKBP1B, polymorphisms with essential hypertension. Clin. Genet. 64, 433-438.
3. Charron, P., Tesson, F., Poirier, O. (1999) Identification of a genetic risk factor for idiopathic dilated cardiomyopathy involvement of a polymorphism in the endothelin receptor type A gene. Eur Heart 20, 1587-1591.
4. Fang, J., Madhavan, S., Cohen, H., Alderman, M. H. (1995) Measures of blood pressure and myocardial infarction in treated hypertensive patients. J. Hypertens. 13, 413-419.
5. Floege, J., Feehally, J. (2000) IgA nephropathy: Recent developments. J. Am. Soc. Nephrol. 11, 2395-2403.
6. Gharavi, A. G., Yan, Y., Scolari, F. (2000) IgA nephropathy, the most common cause of glomerulonephritis, is linked to 6q22-23. Nat. Genet. 26, 354-357.
7. Giusti, R., Neri, M., Angelini, D. (1995) Plasma concentration of endothelin and arterial pressure in patients with APDKD. Contrib. Nephrol. 115, 118-121.
8. Hasegawa, K., Fujiwara, H., Doyma K. (1994) Endothelin-1 selective receptor: the arterial intima of patients with hypertension. Hypertension 23, 288-293.
9. Hataboer, A., Van Dijk, M. A., Bogdanova, A., Coto, E., Saggar-Malik, A. K., San Millan, J. L., Torra, R., Breuning, M. H., Ravine, D. (1999) Comparison of genotypes of polycystic kidney disease types 1 and 2. Lancet 353, 103-107.
10. Hiki, Y., Kokubo, T., Iwase, H. (1999) Underglycosylation of IgAl hinge plays a certain role for its glomerular deposition in IgA nephropathy. J. Am. Soc. Nephrol. 10, 760-769.
11. Kokubo, T., Hashizume, K., Iwase, H. (2000) Humoral immunity against the proline-rich peptide epitope of the IgAl hinge region in IgA nephropathy. Nephrol. Dial. Transplant. 15, 28-33.
12. Magistroni, R., Pei, Y. (2003) IgA nephropathy: A family affair. Nephrology Rounds 4, issue 1.
13. Mestecky, J., Novak, J., Julian, B. A. (2002) Pathogenic potential of galactose-deficient IgAl in IgA nephropathy. Nephrology 7, S92-S99.
14. Nicaud, V., Poirier, O., Behaque, I. (1999) Polymorphisms of the endothelin-A and B receptor genes in relation to blood pressure and myocardial infarction: the Etude Cas-Temoins sur l'Infarctus du Myocarde (ECTIM) Study. Am. J. Hypertens. 12, 304-310.
15. Ong, A. C. M., Newby, L. J., Dashwood, M. R. (2002) Expression and cellular localisation of renal endothelin-1 and endothelin receptor subtypes in autosomal dominant polycystic kidney disease. Exp. Nephrol. 93, 80-86.
16. Pinto-Sietsma, S. J., Hermann, S. M., Schmidt-Peterson, K., Niu, T. (2003) Role of the endothelin-1 gene locus for renal impairment in the general nondiabetic population. J. Am. Soc. Nephrol. 14, 2596-2602.
17. Pirson, Y., Chauveau, D., Grunfeld, J. P. (1998) Autosomal dominant polycystic kidney disease. In: Cameron, J. S., Davison, A. M., Grunfeld, J. P., Kerr, D. N. S., Ritz, E., eds. Oxford Textbook of Clinical Nephrology, Oxford University Press, Oxford, UK 2393-2415.
18. Ravine, D., Walker, R. G., Gibson, R. N., Forrest, S. M., Richards, R. I., Friend, K., Sheffield, L. J., Kincaid-Smith, P., Danks, D. M. (1992) Phenotype and genotype heterogeneity in autosomal dominant polycystic kidney disease. Lancet 340, 1330-1333.
19. Schena, F. P. (2002) For further infestigations in IgA nephropathy the approach from phenotype to genotype is welcome. Clin. Exp. Immunol. 127, 399-401.
20. Schena, F. P., Cerullo, G., Rossini, M., Lanzilotta, S. G., D'Altri, Ch., Manno, C. (2002) Increased risk of end-stage renal disease in familial IgA nephropathy. J. Am. Soc. Nephrol. 13, 453-460.
21. Scolari, F. (2003) Inherited forms of IgA nephropathy. J. Nephrol. 16, 317-320.
22. Suzuki, H., Suzuki, Y., Yamanaka, T., Hirose, S., Nishimura, H., Toei, J., Horikoshi, S., Tomino, Y. (2005) Genome-wide scan in a novel IgA nephropathy model identifies a susceptibility locus on murine chromosome 10, in a region syntenic to human IGAN1 on chromosome 6q22-23. J, Am. Soc. Nephrol. 16, 1289-1299.
23. Syrjanen, J., Mustonen, J., Pastemack, A. (2000) Hypertriglyceridemia and hyperuricemia are risk factors for progression of IgA nephropathy. Nephrol. Dial. Transplant. 15, 34-42.
24. Tahala, C. H., Kamide, K., Takiuchi, S., Kawano, Y., Miyata, T. (2004) Evaluation of the Lys 198Asn and - 134delA genetic polymorphisms of the endothelin-1 gene. Hypertens. Res. 27, 367-71.
25. Tzourio, C., Amrani, M., Poirier, O., Nicaud, V., Bousser, M. G., Alperovitch, A. (2001) Association between migraine and endothelin type A receptor gene polymorphism. Neurology 56, 1273-1277.
26. Woo, D. D., Nguen, D. K., Khatibi, N., Olsen, P. (1997) Genetic identification of two major modifier loci of polycystic kidney disease progression in pcy mice. J. Clin. Invest. 100, 1934-1940.